This is good news. Unless of course you are currently dying of cancer. Treatment for the most common solid tumours remains woefully inadequate, unless you compare it to even more woeful older therapies. Lung cancer, breast cancer, colon cancer, these all remain horrible diseases, that result in an untimely and unpleasant death. We are replacing mortality with expensive morbidity that approaches death asymptotically. This produces a better looking survival curve, but is it actually better?